Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10

Abstract Type 2 diabetes mellitus (T2DM) has rapidly increased worldwide, emerging as the fifth leading cause of death. The treatment of T2DM is challenging due to the side effects of oral hypoglycemic drugs and the limited efficacy of long-term insulin therapy, which can lead to insulin resistance...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiaojiao Zhu, Yanting Hou, Wei Yu, Jingzhou Wang, Xiaolong Chu, Xueting Zhang, Huai Pang, Dingling Ma, Yihan Tang, Menghuan Li, Chenggang Yuan, Jianxin Xie, Cuizhe Wang, Jun Zhang
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Molecular Biomedicine
Subjects:
Online Access:https://doi.org/10.1186/s43556-025-00247-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863596857163776
author Jiaojiao Zhu
Yanting Hou
Wei Yu
Jingzhou Wang
Xiaolong Chu
Xueting Zhang
Huai Pang
Dingling Ma
Yihan Tang
Menghuan Li
Chenggang Yuan
Jianxin Xie
Cuizhe Wang
Jun Zhang
author_facet Jiaojiao Zhu
Yanting Hou
Wei Yu
Jingzhou Wang
Xiaolong Chu
Xueting Zhang
Huai Pang
Dingling Ma
Yihan Tang
Menghuan Li
Chenggang Yuan
Jianxin Xie
Cuizhe Wang
Jun Zhang
author_sort Jiaojiao Zhu
collection DOAJ
description Abstract Type 2 diabetes mellitus (T2DM) has rapidly increased worldwide, emerging as the fifth leading cause of death. The treatment of T2DM is challenging due to the side effects of oral hypoglycemic drugs and the limited efficacy of long-term insulin therapy, which can lead to insulin resistance (IR). Consequently, there is significant in discovering new drugs that have minimal side effects and a pronounced hypoglycemic effect. In obesity, microRNA levels have been implicated in glucose metabolism disorders and T2DM, although many aspects remain unresolved. Here, we confirmed that visceral adipose tissue and serum microRNA-450a-5p content increased under obesity and T2DM, and it was significantly positively associated with fasting blood glucose, triglycerides, cholesterol, low-density lipoproteins-cholesterol levels of the subjects. In high-fat diet (HFD)-induced obese mice, microRNA-450a-5p expression was increased in the serum, liver, and white adipose tissue. Moreover, the adipose Dicer-knockout mouse model was constructed to identify adipose tissue as the main source of microRNA-450a-5p. microRNA-450a-5p could inactivate the insulin signal pathway by targeting the inhibited Dual Specificity Phosphatase 10 (DUSP10) and inducing IR and glucose metabolism disorders in vitro cultured hepatocytes and adipocytes. Additionally, microRNA-450a-5p was found to regulate DUSP10 expression and insulin signaling activity, influencing glucose tolerance and insulin sensitivity across various models, including normal diet, HFD-induced obese, adipose tissue-specific microRNA-450a-5p-knockout, and db/db mice. Furthermore, gallic acid might play a potential role in inhibiting glucose levels by decreasing microRNA-450a-5p expression. Thus, microRNA-450a-5p emerges as an attractive therapeutic target for addressing obesity, IR, and T2DM.
format Article
id doaj-art-54671f0acbee47a480e5b6d968058ec9
institution Kabale University
issn 2662-8651
language English
publishDate 2025-02-01
publisher Springer
record_format Article
series Molecular Biomedicine
spelling doaj-art-54671f0acbee47a480e5b6d968058ec92025-02-09T12:04:37ZengSpringerMolecular Biomedicine2662-86512025-02-016111910.1186/s43556-025-00247-wAdipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10Jiaojiao Zhu0Yanting Hou1Wei Yu2Jingzhou Wang3Xiaolong Chu4Xueting Zhang5Huai Pang6Dingling Ma7Yihan Tang8Menghuan Li9Chenggang Yuan10Jianxin Xie11Cuizhe Wang12Jun Zhang13Medical College of Shihezi UniversityMedical College of Shihezi UniversitySchool of Pharmacy, Xinjiang Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityMedical College of Shihezi UniversityAbstract Type 2 diabetes mellitus (T2DM) has rapidly increased worldwide, emerging as the fifth leading cause of death. The treatment of T2DM is challenging due to the side effects of oral hypoglycemic drugs and the limited efficacy of long-term insulin therapy, which can lead to insulin resistance (IR). Consequently, there is significant in discovering new drugs that have minimal side effects and a pronounced hypoglycemic effect. In obesity, microRNA levels have been implicated in glucose metabolism disorders and T2DM, although many aspects remain unresolved. Here, we confirmed that visceral adipose tissue and serum microRNA-450a-5p content increased under obesity and T2DM, and it was significantly positively associated with fasting blood glucose, triglycerides, cholesterol, low-density lipoproteins-cholesterol levels of the subjects. In high-fat diet (HFD)-induced obese mice, microRNA-450a-5p expression was increased in the serum, liver, and white adipose tissue. Moreover, the adipose Dicer-knockout mouse model was constructed to identify adipose tissue as the main source of microRNA-450a-5p. microRNA-450a-5p could inactivate the insulin signal pathway by targeting the inhibited Dual Specificity Phosphatase 10 (DUSP10) and inducing IR and glucose metabolism disorders in vitro cultured hepatocytes and adipocytes. Additionally, microRNA-450a-5p was found to regulate DUSP10 expression and insulin signaling activity, influencing glucose tolerance and insulin sensitivity across various models, including normal diet, HFD-induced obese, adipose tissue-specific microRNA-450a-5p-knockout, and db/db mice. Furthermore, gallic acid might play a potential role in inhibiting glucose levels by decreasing microRNA-450a-5p expression. Thus, microRNA-450a-5p emerges as an attractive therapeutic target for addressing obesity, IR, and T2DM.https://doi.org/10.1186/s43556-025-00247-wObesitymicroRNA-450a-5pDUSP10T2DM
spellingShingle Jiaojiao Zhu
Yanting Hou
Wei Yu
Jingzhou Wang
Xiaolong Chu
Xueting Zhang
Huai Pang
Dingling Ma
Yihan Tang
Menghuan Li
Chenggang Yuan
Jianxin Xie
Cuizhe Wang
Jun Zhang
Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10
Molecular Biomedicine
Obesity
microRNA-450a-5p
DUSP10
T2DM
title Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10
title_full Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10
title_fullStr Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10
title_full_unstemmed Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10
title_short Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10
title_sort adipose tissue derived microrna 450a 5p induces type 2 diabetes mellitus by downregulating dusp10
topic Obesity
microRNA-450a-5p
DUSP10
T2DM
url https://doi.org/10.1186/s43556-025-00247-w
work_keys_str_mv AT jiaojiaozhu adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT yantinghou adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT weiyu adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT jingzhouwang adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT xiaolongchu adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT xuetingzhang adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT huaipang adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT dinglingma adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT yihantang adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT menghuanli adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT chenggangyuan adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT jianxinxie adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT cuizhewang adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10
AT junzhang adiposetissuederivedmicrorna450a5pinducestype2diabetesmellitusbydownregulatingdusp10